Archer Daniels Midland (ADM), Decatur, IL, has been awarded three U.S. patents that describe the use of concentrated isoflavones in combination with other plant-derived phytochemicals for the treatment of blood-related diseases (No. 6,391,308), cancer (No. 6,395,279) and menopausal symptoms (No. 6,391,309). The patents cover plant-derived compositions enriched with at least two phytochemicals from a group consisting of isoflavones, lignans, saponins, catechins and phenolic acids. U.S. patent No. 6,391,308, covers a composition that is administered for cardiovascular medical conditions such as excessive bloodstream cholesterol, the risk of heart disease, abnormal blood lipid profiles and abnormal vascular effects. The patent also claims a method of treating humans for a cardiovascular condition. U.S. patent No. 6,395,279 covers a composition that is administered to provide treatment for cancer, especially for breast, prostate, skin, colon, urinary and bladder cancer. Lastly, U.S. patent No. 6,391,309 covers a composition that is effective for treating such common menopausal symptoms as hot flashes, osteoporosis, sleep disorders and vaginal dryness. In addition, the patent covers premenstrual syndrome or other problems relating to a reduction of sex hormones and to menstruation.